Qube Research & Technologies LTD Repare Therapeutics Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 299 shares of RPTX stock, worth $1,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
299
Previous 978
69.43%
Holding current value
$1,046
Previous $4,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RPTX
# of Institutions
69Shares Held
36.8MCall Options Held
51.7KPut Options Held
17.7K-
Bvf Inc San Francisco, CA10.3MShares$36.2 Million1.04% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$11.8 Million4.62% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$11.6 Million0.26% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$10.4 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$9.26 Million19.39% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $147M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...